BrightSpring Health Services, I
BTSG
Positions held
Your positionsBTSG isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- BrightSpring Health Services operates in the growing healthcare sector, focusing on health information services, which is increasingly vital as digital health solutions gain traction.
- Revenue increased by 7% compared to the prior quarter, reaching $3.9 billion.
- The company has a strong buy recommendation with a score of 34.00, indicating positive market sentiment.
- The company's trailing P/E ratio is high at 56.42, suggesting that it may be overvalued compared to its earnings.
- Net income for 2025 was only $190.67 million, which is low relative to its revenue of $12.91 billion.
- The operating margin has been relatively low, at 2.29% for 2025, which raises concerns about profitability.
Fundamentals
| Market cap | $12.60B | Enterprise value | $14.96B | Trailing P/E | 56.34 | Forward P/E | 27.94 |
| PEG | — | Price / book | 6.40 | Beta | 1.88 | Dividend yield | 0.00% |
| Revenue growth | 23.0% | Earnings growth | 196.6% | Gross margin | 12.4% | Operating margin | 3.4% |
| Profit margin | 2.5% | ROE | 13.0% | ROA | 4.9% | Debt / equity | 1.16 |
| Current ratio | 1.59 | Free cash flow | $1.03B | Analyst recommendation | strong_buy | Mean target | $78.94 |
| 52w high | $73.75 | 52w low | $27.30 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.6B | $3.6B | $3.3B | $3.1B | — |
| Op margin | 3.4% | 3.4% | 3.0% | 2.6% | 1.5% | — |
| Net income | $84.3M | $149M | $77.1M | $55.8M | $28.2M | — |
| Gross margin | 12.7% | 13.3% | 11.6% | 11.8% | 11.9% | — |
| Gross profit | $493M | $482M | $413M | $392M | $375M | — |
| Operating income | $130M | $121M | $108M | $87.8M | $48.6M | — |
- Revenue +7% vs prior quarter ($3.9B vs $3.6B).
- Gross margin 12.7% (was 13.3% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $12.9B | $10.1B | $7.7B | $7.7B | — |
| Op margin | 2.3% | 1.1% | 0.8% | 3.0% | — |
| Net income | $191M | -$18.1M | -$155M | -$53.9M | — |
| Gross margin | 11.8% | 12.6% | 14.8% | 17.5% | — |
| Gross profit | $1.5B | $1.3B | $1.1B | $1.4B | — |
| Operating income | $295M | $108M | $58.1M | $229M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-03 · Why BrightSpring Health Services (BTSG) Stock Is Up Today
2026-10-01 · BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026
2026-09-30 · BTSG Deploys AI Across Operations: Will It Improve Margins?
2026-09-30 · Option Care Health (OPCH) Draws Fresh Home Care Attention, Is It Still 20% Undervalued?
2026-09-29 · BrightSpring vs. Option Care Health: Which Healthcare Stock Is Better?
2026-09-28 · At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?
2026-09-27 · BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI
2026-09-25 · 3 Market-Beating Stocks to Research Further
2026-09-25 · Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?
2026-09-24 · Best Momentum Stocks to Buy for September 24th
2026-09-23 · BrightSpring Health Services (BTSG) Wins Fund Backing, Is It Still Undervalued?
2026-09-23 · Zacks.com featured highlights include Centene, BrightSpring Health Services and Delek US
Price (daily)
Full chart · RSI · MACD · patterns